|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Stock Screener |
Insider Trading Graph View |
Insider Watch |
Insider Trading - Urovant Sciences Ltd. (UROV)
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise"
- Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2019-06-17 Purchase |
2019-06-19 6:52 pm |
Urovant Sciences Ltd. | UROV | QVT Associates GP LLC QVT Financial Investment Cayman Ltd. 10% Owner |
18,204 | $8.316 | $151,381 | 22,860,012 (Indirect) |
View |
| 2019-06-17 Purchase |
2019-06-19 6:30 pm |
Urovant Sciences Ltd. | UROV | Machado Patrick 10% Owner |
18,204 | $8.316 | $151,381 | 22,860,012 (Indirect) |
View |
| 2019-06-17 Purchase |
2019-06-19 6:30 pm |
Urovant Sciences Ltd. | UROV | SVF Investments (UK) Ltd SoftBank Vision Fund L.P. SVF GP (Jersey) Ltd SVF Holdings (UK) LLP 10% Owner |
18,204 | $8.316 | $151,381 | 22,860,012 (Indirect) |
View |
| 2019-06-17 Purchase |
2019-06-19 6:29 pm |
Urovant Sciences Ltd. | UROV | VIKING GLOBAL PERFORMANCE LLC Viking Global Equities LP Viking Global Equities II LP VGE III Portfolio Ltd. Viking Global Equities Master Ltd. Viking Long Fund GP LLC Viking Long Fund Master Ltd. HALVORSEN OLE ANDREAS Ott David C. Shabet Rose Sharon 10% Owner |
18,204 | $8.316 | $151,381 | 22,860,012 (Indirect) |
View |
| 2019-06-17 Purchase |
2019-06-19 6:28 pm |
Urovant Sciences Ltd. | UROV | VIKING GLOBAL INVESTORS LP Viking Global Opportunities Illiquid Investments Sub-Master LP Viking Global Opportunities Portfolio GP LLC Viking Global Opportunities GP LLC HALVORSEN OLE ANDREAS Ott David C. Shabet Rose Sharon 10% Owner |
18,204 | $8.316 | $151,381 | 22,860,012 (Indirect) |
View |
| 2019-06-17 Purchase |
2019-06-19 6:24 pm |
Urovant Sciences Ltd. | UROV | Dexxon Holdings Ltd. Dexcel Pharma Technologies Ltd. Oren Dan 10% Owner |
18,204 | $8.316 | $151,381 | 22,860,012 (Indirect) |
View |
| 2019-06-17 Purchase |
2019-06-19 6:20 pm |
Urovant Sciences Ltd. | UROV | Lo Andrew 10% Owner |
18,204 | $8.316 | $151,381 | 22,860,012 (Indirect) |
View |
| 2019-06-17 Purchase |
2019-06-19 6:00 pm |
Urovant Sciences Ltd. | UROV | Roivant Sciences Ltd. 10% Owner |
18,204 | $8.316 | $151,381 | 22,860,012 (Direct) |
View |
| 2019-06-12 Purchase |
2019-06-14 6:47 pm |
Urovant Sciences Ltd. | UROV | SVF Investments (UK) Ltd SoftBank Vision Fund L.P. SVF GP (Jersey) Ltd SVF Holdings (UK) LLP 10% Owner |
22,011 | $8.055 | $177,301 | 22,841,808 (Indirect) |
View |
| 2019-06-12 Purchase |
2019-06-14 6:30 pm |
Urovant Sciences Ltd. | UROV | Lo Andrew 10% Owner |
22,011 | $8.055 | $177,301 | 22,841,808 (Indirect) |
View |
| 2019-06-12 Purchase |
2019-06-14 6:16 pm |
Urovant Sciences Ltd. | UROV | QVT Associates GP LLC QVT Financial Investment Cayman Ltd. 10% Owner |
22,011 | $8.055 | $177,301 | 22,841,808 (Indirect) |
View |
| 2019-06-12 Purchase |
2019-06-14 6:16 pm |
Urovant Sciences Ltd. | UROV | VIKING GLOBAL PERFORMANCE LLC Viking Global Equities LP Viking Global Equities II LP VGE III Portfolio Ltd. Viking Global Equities Master Ltd. Viking Long Fund GP LLC Viking Long Fund Master Ltd. HALVORSEN OLE ANDREAS Ott David C. Shabet Rose Sharon 10% Owner |
22,011 | $8.055 | $177,301 | 22,841,808 (Indirect) |
View |
| 2019-06-12 Purchase |
2019-06-14 6:15 pm |
Urovant Sciences Ltd. | UROV | Machado Patrick 10% Owner |
22,011 | $8.055 | $177,301 | 22,841,808 (Indirect) |
View |
| 2019-06-12 Purchase |
2019-06-14 6:15 pm |
Urovant Sciences Ltd. | UROV | VIKING GLOBAL INVESTORS LP Viking Global Opportunities Illiquid Investments Sub-Master LP Viking Global Opportunities Portfolio GP LLC Viking Global Opportunities GP LLC HALVORSEN OLE ANDREAS Ott David C. Shabet Rose Sharon 10% Owner |
22,011 | $8.055 | $177,301 | 22,841,808 (Indirect) |
View |
| 2019-06-12 Purchase |
2019-06-14 6:10 pm |
Urovant Sciences Ltd. | UROV | Dexxon Holdings Ltd. Dexcel Pharma Technologies Ltd. Oren Dan 10% Owner |
22,011 | $8.055 | $177,301 | 22,841,808 (Indirect) |
View |
| 2019-06-12 Purchase |
2019-06-14 6:00 pm |
Urovant Sciences Ltd. | UROV | Roivant Sciences Ltd. 10% Owner |
22,011 | $8.055 | $177,301 | 22,841,808 (Direct) |
View |
| 2019-06-07 Purchase |
2019-06-11 7:05 pm |
Urovant Sciences Ltd. | UROV | QVT Associates GP LLC QVT Financial Investment Cayman Ltd. 10% Owner |
21,338 | $8.307 | $177,247 | 22,819,798 (Indirect) |
View |
| 2019-06-07 Purchase |
2019-06-11 6:46 pm |
Urovant Sciences Ltd. | UROV | SVF Investments (UK) Ltd SoftBank Vision Fund L.P. SVF GP (Jersey) Ltd SVF Holdings (UK) LLP 10% Owner |
21,338 | $8.307 | $177,247 | 22,819,798 (Indirect) |
View |
| 2019-06-07 Purchase |
2019-06-11 6:31 pm |
Urovant Sciences Ltd. | UROV | Machado Patrick 10% Owner |
21,338 | $8.307 | $177,247 | 22,819,798 (Indirect) |
View |
| 2019-06-07 Purchase |
2019-06-11 6:19 pm |
Urovant Sciences Ltd. | UROV | Dexxon Holdings Ltd. Dexcel Pharma Technologies Ltd. Oren Dan 10% Owner |
21,338 | $8.307 | $177,247 | 22,819,798 (Indirect) |
View |
| 2019-06-07 Purchase |
2019-06-11 6:19 pm |
Urovant Sciences Ltd. | UROV | VIKING GLOBAL INVESTORS LP Viking Global Opportunities Illiquid Investments Sub-Master LP Viking Global Opportunities Portfolio GP LLC Viking Global Opportunities GP LLC HALVORSEN OLE ANDREAS Ott David C. Shabet Rose Sharon 10% Owner |
21,338 | $8.307 | $177,247 | 22,819,798 (Indirect) |
View |
| 2019-06-07 Purchase |
2019-06-11 6:14 pm |
Urovant Sciences Ltd. | UROV | VIKING GLOBAL PERFORMANCE LLC Viking Global Equities LP Viking Global Equities II LP VGE III Portfolio Ltd. Viking Global Equities Master Ltd. Viking Long Fund GP LLC Viking Long Fund Master Ltd. HALVORSEN OLE ANDREAS Ott David C. Shabet Rose Sharon 10% Owner |
21,338 | $8.307 | $177,247 | 22,819,798 (Indirect) |
View |
| 2019-06-07 Purchase |
2019-06-11 6:05 pm |
Urovant Sciences Ltd. | UROV | Lo Andrew 10% Owner |
21,338 | $8.307 | $177,247 | 22,819,798 (Indirect) |
View |
| 2019-06-07 Purchase |
2019-06-11 6:00 pm |
Urovant Sciences Ltd. | UROV | Roivant Sciences Ltd. 10% Owner |
21,338 | $8.307 | $177,247 | 22,819,798 (Direct) |
View |
| 2019-06-04 Purchase |
2019-06-06 8:57 pm |
Urovant Sciences Ltd. | UROV | QVT Associates GP LLC QVT Financial Investment Cayman Ltd. 10% Owner |
21,122 | $7.857 | $165,950 | 22,798,460 (Indirect) |
View |
| 2019-06-04 Purchase |
2019-06-06 7:21 pm |
Urovant Sciences Ltd. | UROV | SVF Investments (UK) Ltd SoftBank Vision Fund L.P. SVF GP (Jersey) Ltd SVF Holdings (UK) LLP 10% Owner |
21,122 | $7.857 | $165,950 | 22,798,460 (Indirect) |
View |
| 2019-06-04 Purchase |
2019-06-06 6:25 pm |
Urovant Sciences Ltd. | UROV | Dexxon Holdings Ltd. Dexcel Pharma Technologies Ltd. Oren Dan 10% Owner |
21,122 | $7.857 | $165,950 | 22,798,460 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2019-11-05 Option Award |
2019-11-05 7:45 pm |
N/A N/A |
Urovant Sciences Ltd. | UROV | BANSAL AJAY CFO |
75,000 | $0 | 140,000 (Direct) |
View |
| 2019-11-05 Option Award |
2019-11-05 7:45 pm |
N/A 2029-11-05 |
Urovant Sciences Ltd. | UROV | BANSAL AJAY CFO |
140,000 | $9.66 | 140,000 (Direct) |
View |
| 2019-07-09 Option Award |
2019-07-11 1:17 pm |
N/A 2029-07-09 |
Urovant Sciences Ltd. | UROV | Torti Frank Director |
25,000 | $8.78 | 25,000 (Direct) |
View |
| 2019-07-09 Option Award |
2019-07-11 1:16 pm |
N/A 2029-07-09 |
Urovant Sciences Ltd. | UROV | Robinson James A. Jr. Director |
25,000 | $8.78 | 25,000 (Direct) |
View |
| 2019-07-09 Option Award |
2019-07-11 1:15 pm |
N/A 2029-07-09 |
Urovant Sciences Ltd. | UROV | POTTER MYRTLE S Director |
25,000 | $8.78 | 25,000 (Direct) |
View |
| 2019-07-09 Option Award |
2019-07-11 1:15 pm |
N/A 2029-07-09 |
Urovant Sciences Ltd. | UROV | Legault Pierre Director |
25,000 | $8.78 | 25,000 (Direct) |
View |
| 2019-07-09 Option Award |
2019-07-11 1:14 pm |
N/A 2029-07-09 |
Urovant Sciences Ltd. | UROV | Kurstjens Sef Director |
25,000 | $8.78 | 25,000 (Direct) |
View |
|
© 2005-2019 SecForm4.Com All rights reserved. Archives: 2019 2018 2017 2016 2015 2014 ... Wed, 13 Nov 2019 02:04:02 -0600 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC.
SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |